{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:16:50Z","timestamp":1788445010245,"version":"build-2803163510"},"reference-count":125,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025AFB499"],"award-info":[{"award-number":["2025AFB499"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Foundation of Tongji Hospital","award":["2024A24"],"award-info":[{"award-number":["2024A24"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001272"],"award-info":[{"award-number":["82001272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cent Nerv Syst Dis"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Hyperkinetic movement disorders, including dystonia and choreiform syndromes, are pathophysiologically linked to dysregulated dopamine metabolism within the basal ganglia-thalamo-cortical (BGTC) circuitry. Mounting research highlights dopaminergic hyperactivity as a driver of aberrant signaling and motor symptoms. Vesicular monoamine transporters (VMATs) package monoamines into synaptic vesicles, yet they remain pharmacologically underexplored compared to plasma membrane transporters. Recent advances in VMAT2 inhibitors offer a promising therapeutic avenue for hyperkinetic movement disorders. As a selectivity VMAT2 inhibitor, deutetrabenazine demonstrates unique advantages in dopamine modulation due to deuterium isotope-mediated metabolic stabilization, which extends the dynamics of dopamine receptor occupancy and reduces fluctuations in plasma concentration. Clinically, deutetrabenazine has emerged as a significant therapeutic approach for hyperkinetic movement disorders, with substantial evidence supporting its efficacy in the treatment of chorea associated with Huntington\u2019s disease (HD), tardive dyskinesia (TD), and Tourette syndrome. Future research should prioritize large-scale randomized trials incorporating rigorous subgroup analyses and extended safety monitoring to assess the distinct role of deutetrabenazine in other types of hyperkinetic movement disorders. This review unpacks the workings of VMAT2 inhibitors, paying particular attention to deutetrabenazine\u2019s distinct metabolic profile, and assesses their clinical promise across the range of choreiform disorders to hyperkinetic dystonic syndromes.<\/jats:p>","DOI":"10.1177\/11795735261484948","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:28:38Z","timestamp":1788193718000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Deutetrabenazine in Hyperkinetic Movement Disorders: VMAT2 Modulation From Choreiform Disorders to Hyperkinetic Dystonic Syndromes"],"prefix":"10.1177","volume":"18","author":[{"given":"Yongkang","family":"Fang","sequence":"first","affiliation":[{"name":"Tongji Hospital"},{"name":"Tongji Medical College"},{"name":"Huazhong University of Science and Technology"},{"name":"Huazhong University of Science and Technology"},{"name":"Hubei Stroke Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbing","family":"Lu","sequence":"additional","affiliation":[{"name":"Tongji Hospital"},{"name":"Tongji Medical College"},{"name":"Huazhong University of Science and Technology"},{"name":"Huazhong University of Science and Technology"},{"name":"Hubei Stroke Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Tongji Hospital"},{"name":"Tongji Medical College"},{"name":"Huazhong University of Science and Technology"},{"name":"Huazhong University of Science and Technology"},{"name":"Hubei Stroke Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-3481","authenticated-orcid":false,"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[{"name":"Tongji Hospital"},{"name":"Tongji Medical College"},{"name":"Huazhong University of Science and Technology"},{"name":"Huazhong University of Science and Technology"},{"name":"Hubei Stroke Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2022.02.002"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25532"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(09)70183-8"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2022.05.014"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-018-0529-y"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000246112.19504.61"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22413"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-020-02266-z"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldx019"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107580"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-009-8059-y"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.842"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(17)30236-5"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0831-0"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1258063"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2019.108551"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1403899"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000352"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2018.01.002"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.39"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25475"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-4-383"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.7916\/d8v69x3s"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.06.008"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.09.024"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159x22666240517161444"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073571"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26384"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-021-02339-7"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13020155"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00426-z"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042187"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65211-w"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.7916\/tohm.v0.698"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11569-6"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-023-02845-5"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.08.001"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27123"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02817-1"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0023-6"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhv209"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120944156"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.105"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2408505121"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103302"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26901"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-023-01157-z"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02030-y"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2022.05.001"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-051122-110756"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106403"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23133"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28495"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0806-2"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10549"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007020200026"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14298"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.201711980"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.07.005"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1455504"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2013.12.003"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06727-9"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.02.006"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05906.x"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06926-4"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55361-0"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.05.556211"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00906-z"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0770-9"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S133205"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852917000621"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0874-x"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.06.010"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1429264"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz299"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2445728"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.Nu18041br3c"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0617-493"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S138828"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000003960"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12754"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1161"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.882"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852918001219"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2021.08.003"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-025-00872-9"},{"key":"e_1_3_4_88_2","volume-title":"Medical Genetics Summaries","author":"Dean L","year":"2012","unstructured":"Dean L. Deutetrabenazine Therapy and CYP2D6 Genotype. In: Pratt VM, Scott SA, Pirmohamed M, et al., eds. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2012."},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25051175"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.79"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.874208"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1159\/000502136"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1600018"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.01.006"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.7916\/d8j101xv"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.07.005"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa304"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123104"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8936-x"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2024.2376107"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1500178"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx263"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2012.07677.x"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1674281"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8655"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.S279332"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2021.101032"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02105-w"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.7916\/d8m32w3h"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14327"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28204"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.29397"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29714"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1898948"},{"issue":"2","key":"e_1_3_4_115_2","article-title":"Effect of deutetrabenazine on quality of life in patients with tardive dyskinesia in AIM-TD, a 12-week double-blind, placebo-controlled study [abstract]","volume":"32","author":"Factor S","year":"2017","unstructured":"Factor S, Anderson K, Stamler D, et al. Effect of deutetrabenazine on quality of life in patients with tardive dyskinesia in AIM-TD, a 12-week double-blind, placebo-controlled study [abstract]. Mov Disord. 2017;32(suppl 2): https:\/\/www.mdsabstracts.org\/abstract\/effect-of-deutetrabenazine-on-quality-of-life-in-patients-with-tardive-dyskinesia-in-aim-td-a-12-week-double-blind-placebo-controlled-study\/. Accessed August 29, 2026","journal-title":"Mov Disord"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.773999"},{"key":"e_1_3_4_117_2","volume-title":"AUSTEDO\u00ae (deutetrabenazine) tablets and AUSTEDO XR\u00ae extended-release tablets demonstrate positive real-world impact, with patients reporting improvement in involuntary movements and activities of daily living [IMPACT-TD Registry Part B interim analysis]","author":"Teva P","year":"2025","unstructured":"Teva P. AUSTEDO\u00ae (deutetrabenazine) tablets and AUSTEDO XR\u00ae extended-release tablets demonstrate positive real-world impact, with patients reporting improvement in involuntary movements and activities of daily living [IMPACT-TD Registry Part B interim analysis]; 2025. [Press release]."},{"key":"e_1_3_4_118_2","volume-title":"Patients taking AUSTEDO XR\u00ae (deutetrabenazine) extended-release tablets reported symptom improvement and high satisfaction [Psych Congress 2025 patient survey]","author":"Pharmaceuticals T","year":"2025","unstructured":"Pharmaceuticals T. Patients taking AUSTEDO XR\u00ae (deutetrabenazine) extended-release tablets reported symptom improvement and high satisfaction [Psych Congress 2025 patient survey]; 2025. [Press release]."},{"key":"e_1_3_4_119_2","volume-title":"Deutetrabenazine for tardive dyskinesia yields favourable patient-reported outcomes [Age-stratified survey of deutetrabenazine QD on social and work functioning]","author":"MIMS","year":"2025","unstructured":"MIMS. Deutetrabenazine for tardive dyskinesia yields favourable patient-reported outcomes [Age-stratified survey of deutetrabenazine QD on social and work functioning]; 2025."},{"key":"e_1_3_4_120_2","volume-title":"Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia: effectiveness and value","author":"Institute for Clinical and Economic Review (ICER)","year":"2017","unstructured":"Institute for Clinical and Economic Review (ICER). Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia: effectiveness and value. Final report; 2017. [Patient\/advocacy testimony on return-to-work and productivity]."},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319918"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2023.10.207"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.02.010"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.2463"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.2.243"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29428"}],"container-title":["Journal of Central Nervous System Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795735261484948","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11795735261484948","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795735261484948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:46:42Z","timestamp":1788443202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11795735261484948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":125,"alternative-id":["10.1177\/11795735261484948"],"URL":"https:\/\/doi.org\/10.1177\/11795735261484948","relation":{},"ISSN":["1179-5735","1179-5735"],"issn-type":[{"value":"1179-5735","type":"print"},{"value":"1179-5735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"11795735261484948"}}